Report Overview

The US Postoperative Pain Management Market was valued at USD xx Billion in 2019 and is projected to reach USD XX Billion by 2028, growing at a CAGR of xx% from 2019 to 2028

Post-operative pain includes all types of acute pain that occur due to injuries and resolve in an appropriate healing period. Such pain often responds to analgesic medication, as well as a treatment of the precipitating cause. Post-operative pain could also trigger cardiovascular, respiratory, endocrine, metabolic dysfunctions. Post-operative pain treatment is thus aimed at mobilizing the patient as early as possible. If the patients are not made to undergo a proper post-operative pain treatment, they can potentially develop cardiac problems, chest infections, depression, wound-induced infection, and hypoxia. Post-operative pain treatment has evolved over recent years, with different concepts of how drugs affect the body when used in specific combinations. As per the World Bank, in the U.S. there were 30,537 surgical procedures performed in 2012. As per National Centre for Health Statistics, of overall surgical procedures half of the procedure requires postoperative pain medication which provides a high opportunity for manufacturers. As per the analysis in 2019, the total number of incident cases of postoperative pain in the US was over 60 million. Well-developed healthcare infrastructure and higher healthcare spending coupled with the rising prevalence of cancer and chronic diseases are some of the primary factors expected to drive the growth of the postoperative pain management market in the US

Market Growth Drivers

Despite the many advancements in postoperative pain management, opioids are still considered as the mainstay pain therapy in many settings. All opioids have significant side effects that are limiting their use. One of the major side-effects associated with the use of opioids is respiratory depression. An increasing number of surgical procedures is expected to act as a value-driver to the postoperative pain management market. The increase in trauma cases is the major factor for the growth of the market. The rising research and development expenditure in order to introduce highly effective medications are impacting positively on the growth of the postoperative pain management market. According to CDC, the prescription opioid overdose killed around 16,500 people. The increasing cases of drug overdoses and side-effects associated with postoperative pain drugs are expected to act as a restraint to the overall market